Regulations.gov document
Reference 2 - Ischemia-Triggered Glutamate Excitotoxicity From the Perspective of Glial…
Supporting & Related Material · FDA-2021-P-0267 · posted Mar 4, 2021
Key facts
| Document ID | FDA-2021-P-0267-0005 |
|---|---|
| Title | Reference 2 - Ischemia-Triggered Glutamate Excitotoxicity From the Perspective of Glial Cells RE Citizen Petition from Adrienne Samuels |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2021-P-0267 |
| Posted | Mar 4, 2021 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: